Published
December 20, 2024
Updated
September 29, 2026
Claimants in the $100 million Walgreens Prescription Savings Club settlement, which received final approval on March 31, 2026, are now in the deficiency stage: on September 24, 2026 the administrator said it had finished an initial evaluation of claims and is sending letters to claims missing necessary information. That follow-up takes about eight weeks, and payments for valid claims begin only after responses are processed and the court approves the distribution.
Current Status
The court entered judgment approving the settlement on March 31, 2026, and the April 17, 2025 claim deadline has passed. In an update dated September 24, 2026, the official settlement website says the administrator has performed an initial evaluation of claims and is sending deficiency letters for certain claims that are missing necessary information. The administrator expects that process to take approximately eight weeks. Once responses are received and processed, it will begin distributing payments for valid claims, upon court approval. Not every claim will get a follow-up letter, and only valid claims will be paid. No distribution date has been announced. Claimants who received a letter by email must send supporting documents by the Response Deadline in that letter or the claim will be denied; our deficiency letter response guide explains what to send, and the Walgreens payment timeline covers the steps before payment.StatusPayments Pending; Deficiency Letters Sent
Claim DeadlineApril 17, 2025 — Passed
Settlement Fund$100 Million
Historical ProofVaried by Claimant Type and Amount
What Was the Walgreens Savings Club Lawsuit About?
The litigation alleged that Walgreens failed to include lower prices available through its Prescription Savings Club when reporting the usual and customary prices used to calculate insured prescription reimbursements. Plaintiffs contended that the practice caused insured consumers and third-party payors to pay inflated amounts.Walgreens denied wrongdoing and maintained that it correctly reported its usual and customary prices. The $100 million settlement resolved the disputed claims without trial and also addressed the challenged Savings Club program under the agreement.
Free settlement alerts
Get notified when new class actions open to claims
Join thousands of readers who get the latest class action settlements you may qualify for — delivered straight to your inbox.
Who Was Included?
The class generally covers individuals and entities in the United States and its territories that paid, in whole or in part, for one or more Walgreens prescription drugs using prescription insurance benefits between January 1, 2007, and November 18, 2024. It includes individual consumers and qualifying third-party payors such as health plans and insurers.Excluded groups include Walgreens and certain affiliates, pharmacy benefit managers, specified government entities, people who paid for every prescription without insurance benefits, and categories tied to other litigation or settlements as described in the notice.
How Is the $100 Million Fund Divided?
Court-approved fees, expenses, administration, service awards, and other authorized costs are deducted from the gross fund. The plan of allocation divides the net fund between individual claimants and third-party payors, with 20% allocated to individuals and 80% allocated to the third-party payor pool.Within each pool, payments are pro rata based on recognized claim amounts. No claimant was promised a fixed percentage of personal prescription spending or a particular check simply because the gross settlement totals $100 million.
What Did Individual Claims Require?
Known individual claimants received identifying credentials and estimated their eligible Walgreens spending in ranges. A known individual claiming less than $10,000 generally could rely on the administrator’s identification without submitting purchase documentation, while a known claimant asserting $10,000 or more had to support that amount.Unknown individual claimants had to provide records proving class membership and eligible prescription payments. The claim form and plan, rather than the existence of an insurance card alone, controlled whether the administrator recognized the submission.
What Did Third-Party Payor Claims Require?
Third-party payors had to submit data and documentation sufficient to identify eligible prescription reimbursements for covered members or beneficiaries. Their claims can involve large datasets, exclusions, coordination with vendors, and validation of amounts attributed to Walgreens prescriptions.Because proof rules varied by claimant type and amount, the settlement is accurately labeled proof varies. It should not be summarized as universally no-proof or as requiring the same receipt from every consumer.
What Happened at Final Approval?
The court entered judgment and a final approval order on March 31, 2026. That written judgment—not the earlier scheduled fairness hearing—establishes that the settlement was approved. The administrator then moved into deficiency review and final claims processing.Walgreens’s agreement to settle was not an admission that the plaintiffs’ theory was correct. Final approval means the court accepted the compromise as fair, reasonable, and adequate under the applicable rules.
When Will Payments Be Issued?
No payment date has been announced. The September 24, 2026 update lays out the remaining steps in order: about eight weeks for deficiency letters and responses, processing of those responses, a court order approving the distribution, and then payments to valid claims.Counting eight weeks from September 24 runs to about the third week of November 2026. That is OpenClassActions.com's arithmetic, not an administrator estimate, and it marks the earliest the deficiency stage could wrap up, not a payment date. Given the steps still ahead, including final calculations and a court ruling on the distribution, OpenClassActions.com estimates that payments before the end of 2026 are unlikely and that the first half of 2027 is a more realistic window. That is an estimate, not an official date; payments pending court approval is the accurate current description. Our Walgreens payment timeline walks through each step.
What Is a Deficiency Notice?
A deficiency letter tells a claimant that the administrator's initial review found the claim missing necessary information. The letters began going out after the September 24, 2026 update. Claims that needed supporting records, such as known individuals claiming $10,000 or more, unknown individual claimants and third-party payors, are the most likely to be flagged. Respond with what the letter asks for by the deadline it gives, because only valid claims will be paid.Claimants began receiving the letters by email in late September 2026. The emails cite Section D of the Consumer Claim Form, which reserved the administrator's right to request supporting documents, and ask for a written response by the Response Deadline printed in the letter, sent by mail or email to the contacts the letter lists. Acceptable proof includes records from Walgreens documenting the purchases, or itemized receipts, cancelled checks, invoices, statements or other transaction records showing the amount paid for Walgreens prescriptions filled using insurance during the class period. The letter says a claim with no response by the deadline will be denied, so it is a request to fix the claim rather than a denial. Our guide to what to send in response to a Walgreens deficiency letter covers the documents and steps.
A claimant who has not received a letter does not need to act; the administrator says not every claim will get one. Claimants should verify that a message corresponds to their filed claim and use the official administrator process. OCA cannot cure a deficiency, upload records, or extend an administrator response deadline.
Can Anyone File a New Claim?
No. The extended claim deadline was April 17, 2025. Current work concerns timely submissions and does not reopen the claim portal. A consumer who learns about the litigation after final approval cannot join through OCA.A timely claimant should keep the confirmation, unique identifiers, supporting documents, and any deficiency response. Avoid sharing prescription histories, insurance data, or tax information with an unofficial service.
How Does This Differ From Other Walgreens Cases?
This settlement focuses on prescription pricing and the Walgreens Prescription Savings Club’s relationship to usual and customary price reporting. It is not a general refund for every Walgreens purchase and does not cover unrelated employment, data breach, or retail-pricing disputes.Eligibility requires the use of prescription insurance benefits during the defined period. Cash-only prescription purchases are not automatically covered by this settlement.
What Should Claimants Watch Next?
The next milestones are the end of the roughly eight-week deficiency period and a motion or order asking the court to approve the distribution. Until the official site posts a distribution date, a precise payout date would be speculation.Claimants should monitor official correspondence and the settlement website, and OCA will update this page when the court approves the distribution or payments begin.
Official Information
Review the latest information on the official Walgreens Savings Club settlement website.
Case
Russo et al. v. Walgreen Co.
Case Number
1:17-cv-02246
Court
U.S. District Court, Northern District of Illinois
Class Period
January 1, 2007–November 18, 2024
Settlement Fund
$100,000,000
Claim Deadline
April 17, 2025
Final Approval
March 31, 2026
Payment Stage
Deficiency letters sent September 24, 2026; payments after court approval
Official Website
official Walgreens Savings Club settlement
For more class actions, recalls, and refunds, keep scrolling below.
